Showing results (191-200 of 406) with videos related to
Sort By:
Pageof 41
Annals of Hematology|January 8, 2025
Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carfilzomib and anti-CD38 monoclonal antibodiesLuciano J Costa, Francesca Gay, Ola Landgren, et al.Annals of Hematology|March 2, 2017
Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantationSebastian P Haen, Christiane Groh, Michael Schumm, et al.Blood|May 3, 2002
Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantationHolger Hebart, Senay Daginik, Stefan Stevanovic, et al.Leukemia & Lymphoma|April 26, 2021
Matching adjusted indirect comparisons of efficacy outcomes for idecabtagene vicleucel (ide-cel, bb2121) versus selinexor + dexamethasone and belantamab mafodotin in relapsed and refractory multiple myelomaPaula Rodriguez-Otero, Dieter Ayers, Shannon Cope, et al.European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|June 22, 2026
Dorsal spinal instrumentation in multiple myeloma: postoperative acute kidney injury is associated with mortality, morbidity, and deterioration of bone and muscle statusJulian Kylies, Leon-Gordian Leonhardt, Elias Brauneck, et al.Onkologie|February 5, 2005
Meeting report: primary central nervous system lymphoma: standards of care and future perspectivesUlrich Herrlinger, Agnieszka Korfel, Holger Hebart, et al.Cancer Research|February 12, 2004
Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysisSusanne M Schmidt, Kerstin Schag, Martin R Müller, et al.Cancer Research|June 3, 2006
Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patientsJan Wierecky, Martin R Müller, Stefan Wirths, et al.Journal of Cancer Research and Clinical Oncology|February 18, 2017
Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignanciesSebastian P Haen, Vicky Eyb, Nora Mirza, et al.Oncotargets and Therapy|September 3, 2025
The Role of CELMoD Agents in Multiple MyelomaNiels W C J van de Donk, Nizar J Bahlis, Charlotte Pawlyn, et al.Pageof 41